መነሻ › አኩት ባይፊኖታይፒክ ሊውኬሚያ
በአሜሪካ ለአኩት ባይፊኖታይፒክ ሊውኬሚያ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለአኩት ባይፊኖታይፒክ ሊውኬሚያ የሚደረጉ 37 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Seattle, WA15 ጥናቶች
- Houston, TX11 ጥናቶች
- New York City, NY10 ጥናቶች
- Atlanta, GA9 ጥናቶች
- Durham, NC8 ጥናቶች
- Memphis, TN7 ጥናቶች
- Chicago, IL7 ጥናቶች
- Charlotte, NC6 ጥናቶች
- Aurora, CO6 ጥናቶች
- Baldwin Park, CA6 ጥናቶች
- Portland, OR6 ጥናቶች
- Los Angeles, CA6 ጥናቶች
- Philadelphia, PA6 ጥናቶች
- Dallas, TX6 ጥናቶች
- San Diego, CA5 ጥናቶች
- San Francisco, CA5 ጥናቶች
- Boston, MA5 ጥናቶች
- Clifton, NJ5 ጥናቶች
- Tampa, FL5 ጥናቶች
- Columbus, OH5 ጥናቶች
- Greenburgh, NY5 ጥናቶች
- Nashville, TN5 ጥናቶች
- Fort Worth, TX5 ጥናቶች
- Cincinnati, OH5 ጥናቶች
- Minneapolis, MN5 ጥናቶች
- Mountain View, CA4 ጥናቶች
- Jacksonville, FL4 ጥናቶች
- Denver, CO4 ጥናቶች
- Milwaukee, WI4 ጥናቶች
- Greenville, NC4 ጥናቶች
- St. Louis, MO4 ጥናቶች
- Kansas City, MO4 ጥናቶች
- Akron, OH4 ጥናቶች
- Orange, CA4 ጥናቶች
- Gainesville, FL4 ጥናቶች
- Ann Arbor, MI4 ጥናቶች
- Louisville, KY4 ጥናቶች
- Washington, DC4 ጥናቶች
- Cleveland, OH4 ጥናቶች
- Indianapolis, IN4 ጥናቶች
በክልል
- New Jersey6 ጥናቶች
- New York11 ጥናቶች
- North Carolina11 ጥናቶች
- North Dakota3 ጥናቶች
- Ohio8 ጥናቶች
- Oklahoma5 ጥናቶች
- Oregon6 ጥናቶች
- Pennsylvania6 ጥናቶች
- Rhode Island3 ጥናቶች
- South Carolina3 ጥናቶች
- South Dakota3 ጥናቶች
- Tennessee10 ጥናቶች
- Texas13 ጥናቶች
- Utah3 ጥናቶች
- Virginia3 ጥናቶች
- Washington15 ጥናቶች
- West Virginia3 ጥናቶች
- Wisconsin5 ጥናቶች
- ሃዋይ3 ጥናቶች
- ሉዊዚያና4 ጥናቶች
- ሚሲሲፒ3 ጥናቶች
- ሚሺጋን4 ጥናቶች
- ሚኔሶታ6 ጥናቶች
- ሚዙሪ5 ጥናቶች
- ማሳቹሴትስ5 ጥናቶች
- ሜሪላንድ4 ጥናቶች
- ሜይን3 ጥናቶች
- ኒብራስካ4 ጥናቶች
- ኒው ሃምፕሻየር3 ጥናቶች
- ኔቫዳ3 ጥናቶች
- አላስካ3 ጥናቶች
- አላባማ3 ጥናቶች
- አሪዞና3 ጥናቶች
- አርካንሳስ3 ጥናቶች
- አይዳሆ3 ጥናቶች
- አዮዋ4 ጥናቶች
- ኢሊኖይ7 ጥናቶች
- ኢንዲያና4 ጥናቶች
- ከንታኪ4 ጥናቶች
- ካሊፎርኒያ15 ጥናቶች
- ኮሎራዶ8 ጥናቶች
- ኮነቲከት3 ጥናቶች
- ዲስትሪክት ኦፍ ኮሎምቢያ4 ጥናቶች
- ዴላዌር3 ጥናቶች
- ጆርጂያ9 ጥናቶች
- ፍሎሪዳ9 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT04375631Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07094750A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
30 Days · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT04065399Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT03683433Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እስከ እድሜ 50 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT05322850Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06390319Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ13 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06533579Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06177067Personalized NK Cell Therapy in CBT
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ15 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT02727803Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
ተሳታዮችን በመፈለግ ላይደረጃ 2
6 Months – 65 Years · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06013423Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT07046078Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ1 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT06289673Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07216443Allo HSCT Using RIC and PTCy for Hematological Diseases
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT05805605Registry of Older Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT01137825Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT06551584211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT03670966A Study of Revumenib and Mezigdomide in People With Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT07356154Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT04047641Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
6 Months · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT04195633ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።